Characterization of tumor relevant isocitrate dehydrogenase 1 (IDH1)

被引:0
|
作者
Coleman, Nalani J. [1 ]
Thornberg, Ella [1 ]
Caliger, Danielle [1 ]
Luna, Lucas [1 ]
Sohl, Christal D. [1 ]
机构
[1] San Diego State Univ, San Diego, CA 92182 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1158/1538-7445.AM2020-3732
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3732
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer
    Murugan, Avaniyapuram Kannan
    Bojdani, Ermal
    Xing, Mingzhao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 393 (03) : 555 - 559
  • [2] Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors
    Schaap, Frank G.
    French, Pim J.
    Bovee, Judith V. M. G.
    ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (01) : 32 - 38
  • [3] Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1
    Davis, Mindy I.
    Gross, Stefan
    Shen, Min
    Straley, Kimberly S.
    Pragani, Rajan
    Lea, Wendy A.
    Popovici-Muller, Janeta
    DeLaBarre, Byron
    Artin, Erin
    Thorne, Natasha
    Auld, Douglas S.
    Li, Zhuyin
    Dang, Lenny
    Boxer, Matthew B.
    Simeonov, Anton
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (20) : 13717 - 13725
  • [4] Targeting the isocitrate dehydrogenase 1 (IDH1) metabolic enzyme in prostate cancer
    Gonthier, Kevin
    Weidmann, Cindy
    Fregeau-Proulx, Lilianne
    Audet-Walsh, Etienne
    CANCER RESEARCH, 2020, 80 (16)
  • [5] MUTATION OF ISOCITRATE DEHYDROGENASE (IDH1) IN BRAIN TUMORS AS A PREDICTOR FOR SURVIVAL
    Pesce, G.
    Bleeker, F. E.
    Martin, V
    Mauri, S.
    Lamba, S.
    Boscherini, D.
    Renella, R. R.
    Mazzucchelli, L.
    Bardelli, A.
    Frattin, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (09) : 634 - 634
  • [6] Identification and characterization of isocitrate dehydrogenase 1 (IDH1) as a functional target of marine natural product grincamycin B
    Wang, Zheng
    Li, Zeng-xia
    Zhao, Wen-cao
    Huang, Hong-bo
    Wang, Jia-qi
    Zhang, Hao
    Lu, Jun-yan
    Wang, Rui-na
    Li, Wei
    Cheng, Zhao
    Xu, Wen-long
    Zhu, Di
    Zhou, Li-sha
    Jiang, Wei
    Yu, Long
    Liu, Jun-yan
    Luo, Cheng
    Zhu, Heng
    Ye, Dan
    Pan, Wei-jun
    Ju, Jian-hua
    Dang, Yong-jun
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (05) : 801 - 813
  • [7] Characterizing Secondary-Site Mutations in Isocitrate-Dehydrogenase-1 (IDH1)
    Kandarp, Jyoti
    Kloos, Arnold
    Goerlich, Kerstin
    Kattre, Nadine
    Plenge, Thomas
    Heuser, Michael
    BLOOD, 2024, 144 : 4139 - 4140
  • [8] Discovery of a Novel Chemical Scaffold Against Mutant Isocitrate Dehydrogenase 1 (IDH1)
    Kang, Chung Hyo
    Choi, Sang Un
    Son, You Hwa
    Lee, Heung Kyoung
    Jeong, Hye Gwang
    Yun, Chang-Soo
    Ahn, Sunjoo
    Park, Chi Hoon
    ANTICANCER RESEARCH, 2020, 40 (09) : 4929 - 4935
  • [9] Identification and characterization of isocitrate dehydrogenase 1 (IDH1) as a functional target of marine natural product grincamycin B
    Zheng Wang
    Zeng-xia Li
    Wen-cao Zhao
    Hong-bo Huang
    Jia-qi Wang
    Hao Zhang
    Jun-yan Lu
    Rui-na Wang
    Wei Li
    Zhao Cheng
    Wen-long Xu
    Li-sha Di Zhu
    Wei Zhou
    Long Jiang
    Jun-yan Yu
    Cheng Liu
    Heng Luo
    Wei-jun Zhu
    Jian-hua Dan Ye
    Yong-jun Pan
    Acta Pharmacologica Sinica, 2021, 42 : 801 - 813
  • [10] Isocitrate Dehydrogenase (IDH1/2), a Potential Therapeutic Target in Pancreatic Cancer
    Jensen, K.
    Banerjee, S.
    McGinn, O.
    Nomura, A.
    Saluja, A.
    PANCREAS, 2014, 43 (08) : 1370 - 1370